Cited by 19

Association of fractures with the incidence of amyotrophic lateral sclerosis

Peters, Tracy L., Weibull, Caroline E., Fang, Fang, Sandler, Dale P., Lambert, Paul C., Ye, Weimin, Kamel, Freya·2017·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21678421.2017.1300287

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • When assessing the time since fracture, the association was significant up to 18 years, suggesting that ALS may be impacting bone health.

    “When assessing the time since fracture, however, the association was significant up to 18 years, suggesting that ALS may be impacting bone health [70].”
  • A prospective study investigating the association between fractures and ALS risk found a positive association between fractures and ALS risk and that osteoporotic, non-osteoporotic, traumatic, and non-traumatic were all associated with ALS risk.

    “However, a prospective study investigating the association between fractures and ALS risk found a positive association between fractures and ALS risk and that osteoporotic, non-osteoporotic, traumatic, and non-traumatic were all associated with ALS risk.”
  • It is likely that skeletal function and health are impacted as the disease progresses, increasing the risk of fractures, and not that skull fractures increase the risk of ALS.

    “Therefore, it is likely that skeletal function and health are impacted as the disease progresses, increasing the risk of fractures, and not that skull fractures increase the risk of ALS [70,71,72,79].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. [1]Al-Chalabi A Hardiman O The epidemiology of ALS: a conspiracy of genes, environment and time Nat Rev Neurol 2013 9 617 28 24126629
  2. [2]Campbell AM Williams ER Barltrop D Motor neurone disease and exposure to lead J Neurol Neurosurg Psychiatr 1970 33 877 85 5497881 PMC493607
  3. [3]Kurtzke JF Beebe GW Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths Neurology 1980 30 453 62 7189251
  4. [5]Gawel M Zaiwalla Z Rose FC Antecedent events in motor neuron disease J Neurol Neurosurg Psychiatr 1983 46 1041 3 6655478 PMC491741
  5. [6]Gresham LS Molgaard CA Golbeck AL Smith R Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study Neuroepidemiology 1986 5 29 38 3748267
  6. [7]Granieri E Carreras M Tola R Paolino E Tralli G Eleopra R Motor neuron disease in the province of Ferrara, Italy, in 1964–1982 Neurology 1988 38 1604 8 3419606
  7. [8]Savettieri G Salemi G Arcara A Cassata M Castiglione MG Fierro B A case-control study of amyotrophic lateral sclerosis Neuroepidemiology 1991 10 242 5 1798425
  8. [9]Gunnarsson LG Bodin L Soderfeldt B Axelson O A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents Br J Ind Med 1992 49 791 8 1463680 PMC1039327
  9. [10]Chancellor AM Slattery JM Fraser H Warlow CP Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register J Neurol Neurosurg Psychiatr 1993 56 1200 6 8229031 PMC489821
  10. [11]Strickland D Smith SA Dolliff G Goldman L Roelofs RI Physical activity, trauma, and ALS: a case-control study Acta Neurol Scand 1996 94 45 50 8874593
  11. [12]Cruz DC Nelson LM McGuire V Longstreth WT Jr Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control study Neuroepidemiology 1999 18 101 10 10023133
  12. [13]Kihira T Kanno S Miwa H Okamoto K Kondo T The role of exogenous risk factors in amyotrophic lateral sclerosis in Wakayama, Japan Amyotroph Lateral Scler Other Motor Neuron Disord 2007 8 150 6 17538776
  13. [15]Seals RM Hansen J Gredal O Weisskopf MG Physical trauma and amyotrophic lateral sclerosis: A population-based study using Danish national registries Am J Epidemiol 2015 183 294 301 PMC4753279 26825926
  14. [16]van Geel TA van den Bergh JP Dinant GJ Geusens PP Individualizing fracture risk prediction Maturitas 2010 65 143 8 20053513
  15. [17]Ensrud KE Epidemiology of fracture risk with advancing age J Gerontol A Biol Sci Med Sci 2013 68 1236 42 23833201
  16. [18]Fang F Kwee LC Allen KD Umbach DM Ye W Watson M Association between blood lead and the risk of amyotrophic lateral sclerosis Am J Epidemiol 2010 171 1126 33 20406759 PMC2877471
  17. [19]Mallette LE Patten B Cook JD Engel WK Calcium metabolism in amyotrophic lateral sclerosis Dis Nerv Syst 1977 38 457 61 862504
  18. [20]Melmed S Braunstein GD Endocrine function in amyotrophic lateral sclerosis. A review Neurol Clin 1987 5 33 42 3550415
  19. [21]Sato Y Honda Y Asoh T Kikuyama M Oizumi K Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis Eur Neurol 1997 37 225 9 9208262
  20. [22]Johnson JO Mandrioli J Benatar M Abramzon Y Van Deerlin VM Trojanowski JQ Exome sequencing reveals VCP mutations as a cause of familial ALS Neuron 2010 68 857 64 21145000 PMC3032425
  21. [23]Lagerlund M Bellocco R Karlsson P Tejler G Lambe M Socio-economic factors and breast cancer survival--a population-based cohort study (Sweden) Cancer Causes Control 2005 16 419 30 15953984
  22. [24]Ludvigsson JF Andersson E Ekbom A Feychting M Kim JL Reuterwall C External review and validation of the Swedish national inpatient register BMC Public Health 2011 11 450 21658213 PMC3142234
  23. [26]Ludvigsson JF Almqvist C Bonamy AK Ljung R Michaelsson K Neovius M Registers of the Swedish total population and their use in medical research Eur J Epidemiol 2016 31 125 36 26769609
  24. [27]Kurian KM Forbes RB Colville S Swingler RJ Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register J Neurol Neurosurg Psychiatr 2009 80 84 7 19091712
  25. [28]St Germaine-Smith C Metcalfe A Pringsheim T Roberts JI Beck CA Hemmelgarn BR Recommendations for optimal ICD codes to study neurologic conditions: a systematic review Neurology 2012 79 1049 55 22914826 PMC3430709
  26. [30]Brennan SL Holloway KL Williams LJ Kotowicz MA Bucki-Smith G Moloney DJ The social gradient of fractures at any skeletal site in men and women: data from the Geelong Osteoporosis Study Fracture Grid Osteoporos Int 2015 26 1351 9 25572043
  27. [31]Sutedja NA Veldink JH Fischer K Kromhout H Wokke JH Huisman MH Lifetime occupation, education, smoking, and risk of ALS Neurology 2007 69 1508 14 17923612
  28. [32]Roos PM Osteoporosis in neurodegeneration J Trace Elem Med Biol 2014 28 418 21 25220531
  29. [33]Jackson CE Amato AA Bryan WW Wolfe GI Sakhaee K Barohn RJ Primary hyperparathyroidism and ALS: is there a relation? Neurology 1998 50 1795 9 9633730
  30. [34]Karam C Barrett MJ Imperato T MacGowan DJ Scelsa S Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis J Clin Neurosci 2013 20 1550 3 23815870
  31. [35]Camu W Tremblier B Plassot C Alphandery S Salsac C Pageot N Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis Neurobiol Aging 2014 35 1198 205 24378089
  32. [36]Gianforcaro A Hamadeh MJ Dietary vitamin D3 supplementation at 10x the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study CNS Neurosci Ther 2012 18 547 57 22591278 PMC6493637
  33. [37]Long Kv Nguyen LT Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms Mol Brain 2013 6 16 23570271 PMC3641959
  34. [38]ALS Untangled No. 24: Vitamin D Amyotroph Lateral Scler Frontotemporal Degener 2014 15 318 20 24689759
  35. [39]Kamel F Umbach DM Hu H Munsat TL Shefner JM Taylor JA Lead exposure as a risk factor for amyotrophic lateral sclerosis Neurodegener Dis 2005 2 195 201 16909025
  36. [40]Hu H Payton M Korrick S Aro A Sparrow D Weiss ST Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study Am J Epidemiol 1996 144 749 59 8857824
  37. [41]Nash D Magder LS Sherwin R Rubin RJ Silbergeld EK Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994 Am J Epidemiol 2004 160 901 11 15496543
  38. [42]Gulson BL Mizon KJ Korsch MJ Palmer JM Donnelly JB Mobilization of lead from human bone tissue during pregnancy and lactation--a summary of long-term research Sci Total Environ 2003 303 79 104 12568766
  39. [43]Escribano A Revilla M Hernandez ER Seco C Gonzalez-Riola J Villa LF Effect of lead on bone development and bone mass: a morphometric, densitometric, and histomorphometric study in growing rats Calcif Tissue Int 1997 60 200 3 9056171
  40. [44]Beier EE Maher JR Sheu TJ Cory-Slechta DA Berger AJ Zuscik MJ Heavy metal lead exposure, osteoporotic-like phenotype in an animal model, and depression of Wnt signaling Environ Health Perspect 2013 121 97 104 23086611 PMC3552813
  41. [45]Campbell JR Rosier RN Novotny L Puzas JE The association between environmental lead exposure and bone density in children Environ Health Perspect 2004 112 1200 3 15289167 PMC1247482

Cited by

Sorted by citations

Authors
Peters, T. L., Weibull, C. E., Fang, F., Sandler, D. P., Lambert, P. C., Ye, W., & Kamel, F.
Affiliations
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
  • Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA, and
Venue
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Published
2017-03-20
Volume
18
Issue
5-6
Pages
419-425
ISSN
  • 2167-8421
  • 2167-9223
Cited by
19
References
2
Language
en
Funders
  • Swedish Research Council (80748301, 2015-03170)
  • Swedish Research Council for Health (2011-0172)
  • Karolinska Institutet
  • the National Institutes of Health/Karolinska Institutet graduate partnership programme
  • Intramural Research Program of National Institutes of Health
  • National Institute of Environmental Health Sciences (Z01-ES-049005)
  • EU Joint Programme - Neurodegenerative Disease Research (JPND) project
  • the Intramural Research Program of National Institutes of Health
  • the Swedish Research Council for Health, Working life, and Welfare (2011-0172)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review